These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2832599)

  • 41. Evaluation of crystals in formalin-fixed, paraffin-embedded tissue sections for the differential diagnosis of pseudogout, gout, and tumoral calcinosis.
    Shidham V; Chivukula M; Basir Z; Shidham G
    Mod Pathol; 2001 Aug; 14(8):806-10. PubMed ID: 11504841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunoglobulins on the surface of monosodium urate crystals: an immunoelectron microscopic study.
    Bardin T; Varghese Cherian P; Schumacher HR
    J Rheumatol; 1984 Jun; 11(3):339-41. PubMed ID: 6737374
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gout: update on some pathogenic and clinical aspects.
    Lioté F; Ea HK
    Rheum Dis Clin North Am; 2006 May; 32(2):295-311, vi. PubMed ID: 16716881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative study of uric acid renal elimination in the gout patients and normal patients in spontaneous or experimentally increased or decreased uricemia].
    Prost A; Fontenaille C; Guiheneuc P; Héron B; Lucas J
    Rev Rhum Mal Osteoartic; 1974 Jan; 41(1):33-9. PubMed ID: 4820524
    [No Abstract]   [Full Text] [Related]  

  • 45. Superoxide anion production and phagocytosis of crystals by cultured endothelial cells.
    Falasca GF; Ramachandrula A; Kelley KA; O'Connor CR; Reginato AJ
    Arthritis Rheum; 1993 Jan; 36(1):105-16. PubMed ID: 8381009
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Membranolytic effects of crystalline monosodium urate monohydrate.
    Burt HM; Kalkman PH; Mauldin D
    J Rheumatol; 1983 Jun; 10(3):440-8. PubMed ID: 6887167
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms of uric acid crystal-mediated autoinflammation.
    Martinon F
    Immunol Rev; 2010 Jan; 233(1):218-32. PubMed ID: 20193002
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets.
    Punzi L; Scanu A; Ramonda R; Oliviero F
    Autoimmun Rev; 2012 Nov; 12(1):66-71. PubMed ID: 22884557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Uric acid as a danger signal in gout and its comorbidities.
    Rock KL; Kataoka H; Lai JJ
    Nat Rev Rheumatol; 2013 Jan; 9(1):13-23. PubMed ID: 22945591
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tophus-derived monosodium urate monohydrate crystals are biologically much more active than synthetic counterpart.
    Stankovíc A; Front P; Barbara A; Mitrovíc DR
    Rheumatol Int; 1991; 10(6):221-6. PubMed ID: 2041978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout.
    Schett G; Schauer C; Hoffmann M; Herrmann M
    RMD Open; 2015; 1(Suppl 1):e000046. PubMed ID: 26557370
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urate crystals in gout.
    Faure G; Netter P
    J Rheumatol; 1978; 5(3):353-5. PubMed ID: 748559
    [No Abstract]   [Full Text] [Related]  

  • 53. A structural approach to pathological crystallizations. Gout: the possible role of albumin in sodium urate crystallization.
    Perl-Treves D; Addadi L
    Proc R Soc Lond B Biol Sci; 1988 Nov; 235(1279):145-59. PubMed ID: 2907144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Innate immunity in triggering and resolution of acute gouty inflammation.
    Rose DM; Liu-Bryan R
    Curr Rheumatol Rep; 2006 Jun; 8(3):209-14. PubMed ID: 16901079
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Pathogenesis of the acute attack of gout. 1: solubility of monosodium urate ].
    Carcassi A
    Reumatismo; 1976; 28(4):181-6. PubMed ID: 1032564
    [No Abstract]   [Full Text] [Related]  

  • 56. Decreased Expression of CD14 in MSU-Mediated Inflammation May Be Associated with Spontaneous Remission of Acute Gout.
    Duan L; Luo J; Fu Q; Shang K; Wei Y; Wang Y; Li Y; Chen J
    J Immunol Res; 2019; 2019():7143241. PubMed ID: 31312662
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Growth patterns of monosodium urate monohydrate (gouty and urinary) crystals in gel: An in vitro study.
    Ahmed S; Hasan MM; Mahmood ZA
    Pak J Pharm Sci; 2017 Nov; 30(6):2101-2108. PubMed ID: 29175779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathogenesis of gout.
    Choi HK; Mount DB; Reginato AM; ;
    Ann Intern Med; 2005 Oct; 143(7):499-516. PubMed ID: 16204163
    [No Abstract]   [Full Text] [Related]  

  • 59. Sodium and potassium urate crystals differ in their inflammatory potential.
    Schorn C; Janko C; Munoz L; Schulze C; Strysio M; Schett G; Herrmann M
    Autoimmunity; 2009 May; 42(4):314-6. PubMed ID: 19811287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. What stops a gouty attack?
    Terkeltaub RA
    J Rheumatol; 1992 Jan; 19(1):8-10. PubMed ID: 1556704
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.